ArticleOncology reports2024

Engineered extracellular vesicles with polypeptide for targeted delivery of doxorubicin against EGFR‑positive tumors.

Yuqing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.